Recognized throughout the world for her expertise in ocular oncology, Dr. Correa specializes in the diagnosis and treatment of eye tumors such as ocular melanoma, retinoblastoma, ocular metastasis, and choroidal hemangioma.
Ocular oncologists are highly specialized ophthalmic surgeons who diagnose and treat tumors and pseudotumors of the eye. Ocular tumors can be benign or malignant and affect patients ranging from young children to older adults. Treatment of these tumors involves various forms of laser and radiation therapy, intraocular injections, delicate biopsy procedures, and advanced microsurgical techniques.
Dr. Correa most recently served as the Tom Clancy Endowed Professor of Ophthalmology at the Wilmer Eye Institute of Johns Hopkins University School of Medicine in Baltimore. In this position, she built an excellent ocular oncology program that has drawn patients from across the U.S. and throughout the world. She previously served as professor of ophthalmology and Mary Knight Asbury Chair of Ophthalmic Pathology & Ocular Oncology at the University of Cincinnati College of Medicine.
Dr. Correa’s research focuses on the use of artificial intelligence to distinguish benign from malignant ocular tumors based on imaging characteristics. She will conduct her research at Bascom Palmer’s ocular oncology laboratory.
“Dr. Correa is one of the leading authorities on ocular oncology, and her recruitment to Bascom Palmer will allow us to achieve our ambitious goal of creating the foremost international destination for patients with eye tumors,” said J. William Harbour, M.D., professor of ophthalmology, vice chair for translational research, director of the Bascom Palmer ocular oncology service, holder of the Mark J. Daily Endowed Chair in Ophthalmology, and associate director for basic science at Sylvester Comprehensive Cancer Center.
Her academic career includes more than 150 peer-reviewed original scientific publications, book chapters and abstracts. She currently serves as a member of the editorial boards of JAMA Ophthalmology and Translational Vision Science Technology Journal, and is the ocular oncology section editor for EyeNet magazine.